AP

Alkeus Pharmaceuticals at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Alkeus Pharmaceuticals at BIO-Europe 2026 in Cologne: 1 session (1 panel discussion).

OrganizationBIO-Europe 2026 Attendance
AP
Alkeus Pharmaceuticals
Cambridge, Massachusetts
Biotech
Develops gildeuretinol, a deuterated vitamin A, for Stargardt disease and other retinal diseases.
Panel
Tue Nov 10
09:45–10:45
China’s Clinical Revolution: From Regional Player to Global Innovation Engine
Why global drug companies license more drugs from Chinese biotechs, and how China's fast trials and changing rules can speed worldwide development.
with SILREAL, Elpiscience, MSQ Ventures

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Alkeus Pharmaceuticals

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction